ANI Pharmaceuticals Inc (ANIP NASDAQ) stock market data APIs
$98.0442
0.17(0.2%)
as of September 12, 2025
Try our APIs with
free plan!
ANI Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Prev. Close
98.0442
Open
98.2117
High
98.2899
Low
96.641
52 wk Range
52.5-99.5
Market Cap
2 119 M
Shares Outstanding
21 689 K
Revenue
747 M
EPS
1.8
Beta
0.633
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ANI Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ANI Pharmaceuticals Inc data using free add-ons & libraries
Get ANI Pharmaceuticals Inc Fundamental Data
ANI Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 747 M
- EBITDA: 104 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-08
- EPS/Forecast: 1.4
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ANI Pharmaceuticals Inc News
New
Should ANI Pharmaceuticals’ (ANIP) Ambitious 2025 Revenue Forecast Prompt Action From Investors?
Earlier this week, ANI Pharmaceuticals issued earnings guidance for 2025, projecting total revenues of US$818 million to US$843 million, representing an estimated 33% to 37% increase from the previous...
JNJ Seeks EU Approval for Oral Psoriasis Drug Icotrokinra
Johnson & Johnson JNJ has submitted a regulatory filing to the European Medicines Agency (EMA) to seek approval for its investigational oral peptide, icotrokinra, to treat moderate-to-severe plaque ps...
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that...
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Adagene Inc. Sponsored ADR (ADAG) one of those stocks right n...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
